A detailed history of American International Group, Inc. transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, American International Group, Inc. holds 19,397 shares of VYGR stock, worth $147,223. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,397
Previous 15,787 22.87%
Holding current value
$147,223
Previous $133,000 35.34%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$7.15 - $10.84 $25,811 - $39,132
3,610 Added 22.87%
19,397 $180,000
Q4 2023

Feb 13, 2024

SELL
$6.28 - $8.81 $401 - $563
-64 Reduced 0.4%
15,787 $133,000
Q3 2023

Nov 13, 2023

BUY
$7.55 - $11.25 $4,258 - $6,345
564 Added 3.69%
15,851 $122,000
Q2 2023

Aug 04, 2023

BUY
$6.94 - $13.99 $106,091 - $213,865
15,287 New
15,287 $175,000
Q2 2021

Aug 13, 2021

SELL
$3.94 - $5.44 $59,344 - $81,937
-15,062 Closed
0 $0
Q1 2021

May 07, 2021

BUY
$4.61 - $9.04 $179 - $352
39 Added 0.26%
15,062 $71,000
Q4 2020

Feb 12, 2021

SELL
$7.15 - $12.28 $3,081 - $5,292
-431 Reduced 2.79%
15,023 $107,000
Q3 2020

Nov 04, 2020

SELL
$10.01 - $13.75 $3,523 - $4,840
-352 Reduced 2.23%
15,454 $165,000
Q2 2020

Aug 12, 2020

BUY
$8.05 - $14.21 $12,195 - $21,528
1,515 Added 10.6%
15,806 $199,000
Q1 2020

May 04, 2020

SELL
$6.8 - $14.66 $5,616 - $12,109
-826 Reduced 5.46%
14,291 $131,000
Q4 2019

Feb 05, 2020

SELL
$12.82 - $16.85 $1,615 - $2,123
-126 Reduced 0.83%
15,117 $211,000
Q3 2019

Nov 08, 2019

SELL
$16.31 - $28.29 $1,745 - $3,027
-107 Reduced 0.7%
15,243 $262,000
Q2 2019

Aug 13, 2019

BUY
$19.18 - $27.88 $32,030 - $46,559
1,670 Added 12.21%
15,350 $418,000
Q1 2019

May 06, 2019

SELL
$8.0 - $19.66 $3,552 - $8,729
-444 Reduced 3.14%
13,680 $262,000
Q4 2018

Feb 13, 2019

SELL
$8.59 - $18.05 $919 - $1,931
-107 Reduced 0.75%
14,124 $133,000
Q3 2018

Nov 09, 2018

BUY
$17.11 - $21.74 $4,380 - $5,565
256 Added 1.83%
14,231 $269,000
Q2 2018

Aug 08, 2018

BUY
$16.76 - $23.92 $51,520 - $73,530
3,074 Added 28.2%
13,975 $273,000
Q1 2018

May 07, 2018

SELL
$16.16 - $31.31 $9,469 - $18,347
-586 Reduced 5.1%
10,901 $205,000
Q4 2017

Feb 09, 2018

BUY
$12.26 - $25.88 $21,160 - $44,668
1,726 Added 17.68%
11,487 $191,000
Q3 2017

Nov 09, 2017

BUY
$8.37 - $20.59 $81,699 - $200,978
9,761
9,761 $201,000

Others Institutions Holding VYGR

About Voyager Therapeutics, Inc.


  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $293M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.